NEW YORK, Dec. 19 (GenomeWeb News) - AstraZeneca has extended its license for Linguamatics' text-mining software, the natural language processing company said today.
AstraZeneca signed the original license agreement in October 2003 to use the technology for its drug discovery and development programs.
Linguamatics' interactive text-mining system, I2E, analyzes research literature and other text. The company said that it partners with BioWisdom's Intelligence Network to enhance its search performance over other text-mining approaches.
No financial details of the deal were disclosed.